Torrey Pines Institute for Molecular Studies, San Diego, California, United States of America.
PLoS One. 2013 Oct 17;8(10):e76546. doi: 10.1371/journal.pone.0076546. eCollection 2013.
Autoreactive memory CD4(+) T cells play a critical role in the development of type 1 diabetes, but it is not yet known how the clonotypic composition and TCRβ repertoire of the memory CD4(+) T cell compartment changes during the transition from prediabetes to diabetes. In this study, we used high-throughput sequencing to analyze the TCRβ repertoire of sorted islet-infiltrating memory CD4(+)CD44(high) T cells in 10-week-old prediabetic and recently diabetic NOD mice. We show that most clonotypes of islet-infiltrating CD4(+)CD44(high) T cells were rare, but high-frequency clonotypes were significantly more common in diabetic than in prediabetic mice. Moreover, although the CD4(+)CD44(high) TCRβ repertoires were highly diverse at both stages of disease development, dominant use of TRBV1 (Vβ2), TRBV13-3 (Vβ8.1), and TRBV19 (Vβ6) was evident in both prediabetic and diabetic mice. Our findings strongly suggest that therapeutic targeting of cells specifically expressing the dominant TCRβ might reduce pancreatic infiltration in prediabetic mice and attenuate the progression to diabetes.
自身反应性记忆 CD4(+)T 细胞在 1 型糖尿病的发展中起着关键作用,但目前尚不清楚在从糖尿病前期到糖尿病的转变过程中,记忆 CD4(+)T 细胞群的克隆型组成和 TCRβ 库如何变化。在这项研究中,我们使用高通量测序分析了 10 周龄糖尿病前期和近期糖尿病 NOD 小鼠胰岛浸润记忆 CD4(+)CD44(high)T 细胞分选的 TCRβ 库。我们表明,胰岛浸润 CD4(+)CD44(high)T 细胞的大多数克隆型都是罕见的,但高频克隆型在糖尿病小鼠中明显比在糖尿病前期小鼠中更为常见。此外,尽管在疾病发展的两个阶段,CD4(+)CD44(high)TCRβ 库都具有高度多样性,但在糖尿病前期和糖尿病小鼠中都明显存在 TRBV1(Vβ2)、TRBV13-3(Vβ8.1)和 TRBV19(Vβ6)的优势使用。我们的研究结果强烈表明,针对特异性表达优势 TCRβ 的细胞进行治疗性靶向可能会减少糖尿病前期小鼠的胰腺浸润,并减轻向糖尿病的进展。